Search Virginia Mason News
Virginia Mason Experts Will Provide Cancer-Risk Assessments April 27 at Seattle’s Westlake Center
SEATTLE – (April 23, 2015) – Virginia Mason physicians and care professionals will provide information about cancer prevention and screening guidelines, free of charge, from 11 a.m. until 4 p.m., Monday, April 27, on the public plaza outside Westlake Center in downtown Seattle.
Additionally, visitors can complete a questionnaire about lifestyle, age and health and discuss the results with an on-site expert who will assess their personal cancer risks and determine whether scheduling a cancer screening is the appropriate next step.
“Cancer is a leading cause of death among men and women in our nation,” said John Corman, MD, medical director, Floyd & Delores Jones Cancer Institute at Virginia Mason. “We encourage people to be proactive, to learn about their risk for developing cancer, and talk with their health care providers about this important issue.
“The earlier cancer is detected,” he added, “the better the chances it can be cured.”
The information booth outside Westlake Center will be near a large outdoor ice sculpture that spells out CANCER and was created for the Virginia Mason-sponsored public event. Joining Dr. Corman at the booth will be pulmonologist Steve Kirtland, MD; radiation oncologist Kas Badiozamani, MD; and Eve Kahn, ARNP, a nurse practitioner who specializes in breast cancer.
The Floyd & Delores Jones Cancer Institute at Virginia Mason offers advanced care for 16 types of cancer by experts in an environment of hope and healing. The institute brings all aspects of care − from physicians, chemotherapy infusions, radiation therapy and supportive care − to patients in the most convenient way. Additionally, Virginia Mason experts employ molecular biology, DNA sequencing and bioinformatics to determine whether a person’s cancer could be genetic or hereditary. If it appears the cancer may be genetic, the individual’s siblings and children are offered genetic testing to evaluate their risk for the disease.
In 2013, cancer caused 584,881 deaths in the United States, second only to heart disease, according to the U.S. Centers for Disease Control and Prevention. Virginia Mason has some of the highest five-year survival rates among individuals treated for breast, bladder, lung, ovarian and pancreatic cancer when compared to national statistics compiled by the National Cancer Database and National Cancer Institute.
“The superior outcomes at Virginia Mason reflect our team’s expertise and commitment to providing the highest quality and most appropriate care,” Dr. Corman said.
Virginia Mason, a leading provider of cancer care in the Pacific Northwest, has been accredited by the College of Surgeons Commission on Cancer since 1941. This is the longest-running accreditation by the commission among Seattle hospitals and the third-longest accreditation by the commission in the nation.
About Virginia Mason
Virginia Mason, founded in 1920, is a nonprofit regional health care system in Seattle that serves the Pacific Northwest. Virginia Mason employs about 6,000 people and includes a 336-bed acute-care hospital; a primary and specialty care group practice of more than 460 physicians; regional medical centers throughout the Puget Sound area; and Bailey-Boushay House, the first skilled-nursing and outpatient chronic care management program in the U.S. designed and built specifically to meet the needs of people with HIV/AIDS. Benaroya Research Institute at Virginia Mason is internationally recognized for its breakthrough autoimmune disease research. Virginia Mason was the first health system to apply lean manufacturing principles to health care delivery to eliminate waste, lower cost, and improve quality and patient safety.
To learn more about Virginia Mason, please visit Facebook.com/VMcares or follow @VirginiaMason on Twitter. To learn how Virginia Mason is transforming health care and to join the conversation, visit our blog at VirginiaMasonBlog.org.
Virginia Mason Media Relations